Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis | Zendy

AI Assistant Blog Pricing

Open Access

Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis

Author(s) -

G. Ya. Shvarts

Publication year - 2005

Publication title -

ukrainian neurosurgical journal

Language(s) - English

Resource type - Journals

eISSN - 2663-9092

pISSN - 2663-9084

DOI - 10.25305/unj.132316

Subject(s) - glatiramer acetate , multiple sclerosis , medicine , physical medicine and rehabilitation , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.